Elevate MedTech notes that the FDA has updated its public list of authorised AI-enabled medical devices, including foundation models and large language models, so that developers, clinicians, and patients can tell when LLM-based functionality is present in a device.
Public source
Publisher name
Public post
The FDA has updated its public list of authorised AI-enabled medical devices, and one detail is worth more attention than the update itself. The agency has signalled it…
Company
Elevate MedTech
Regulatory Affairs Consulting | Software as a Medical Device | Compliance | Audit Preparation | Internal Auditor | QMS
- Industry
- Business Consulting and Services
- Location
- Christchurch, NZ
- Company size
- 2–10 employees
About Elevate MedTech
Elevate MedTech brings together deep regulatory, clinical, and commercial expertise to support innovators across the full medical device and digital health pathway. From concept to market access, we guide manufacturers through design, compliance, and international approvals with precision and practical insight. With a strong presence in New Zealand and Australia and connections across the UK, EU, and US, Elevate MedTech provides end-to-end support for regulatory affairs, quality management, and clinical validation. Our multidisciplinary team delivers: ⏺ Regulatory consulting and training covering SaMD, IVDs, QMS, cybersecurity, human factors, and technical documentation. ⏺ QA/RA and clinical consulting, including fractional QA/RA, audit preparation, and independent reviews. ⏺ Clinical insight from practising medical specialists. ⏺ Biocompatibility and toxicology expertise. ⏺ Trusted sponsorship for medical devices in New Zealand and Australia. ⏺ Digital tools such as Regulatory Radar and Post-Market Radar to streamline compliance and surveillance. ⏺ Commercialisation strategy and go-to-market support for MedTech, Digital Health, and BioPharma companies. Through our Medical Device University, tailored seminars, and workshops, we empower clients with the knowledge and confidence to meet global regulatory expectations and accelerate market success. Rely on Elevate MedTech as your trusted partner for regulatory affairs, clinical consulting, and international market access. Contact us at info@elevate-med.tech or visit elevate-med.tech
See moreLatest activity
Latest activity from Elevate MedTech
4 signals
Legal & Regulatory
Elevate MedTech notes that IEC 62366-3 is a committee draft under review for usability engineering guidance for AI and ML-based devices.
Technology & Infrastructure
Elevate MedTech was informed that Health Canada launched the Canadian Clinical Trial Search Portal to replace the older Clinical Trials Database.
Legal & Regulatory
Elevate MedTech was informed that Health Canada published new guidance on registering clinical trials and disclosing results in Canada.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
ADHOCON
ADHOCON notes that the FDA has a discussion paper and a pilot project named TEMPO for generative-AI medical devices.
Legal & Regulatory
LOAD
LOAD highlights that the EU AI Act moved its MedTech deadline to 2 August 2028, changing high-risk obligations for AI-powered software tied to regulated medical devices.
Legal & Regulatory
John Snow Labs
John Snow Labs’ AI Governance Framework conforms to 300+ laws, regulations, and industry standards worldwide, covering nine pillars including risk management, safety, privacy, transparency, fairness, and acceptable use.
Legal & Regulatory
Veeva Systems
Veeva Systems reported that the FDA granted four AI-powered devices, including TEMPO: the Technology-Enabled Meaningful Patient Outcomes pilot, reach Medicare patients before any held full marketing authorization.
Legal & Regulatory
STAT